Serina Therapeutics Inc (SER)
Healthcare
Biotechnology
2.00 $
-2.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Serina Therapeutics Inc (SER) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -18 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| -8.4 | -6.3 | -8.0 | -10 | -7.8 | -2.3 | -2.1 | -2.5 | -17 | -18 | |
| 0.8 | 0.7 | 0.5 | 1.0 | 1.3 | 0.0 | 0.1 | 0.1 | 0.2 | 0.1 | |
| – | – | – | – | – | 0.1 | 0.0 | 0.0 | 2.6 | 3.8 | |
| 1.3 | 0.8 | 0.2 | -0.4 | -0.3 | -0.8 | 0.0 | 0.1 | -3.3 | 1.5 | |
| 0.0 | 0.0 | 1.9 | 0.6 | 0.0 | 0.1 | 0.0 | 0.5 | 0.0 | 0.1 | |
| 0.0 | 0.0 | 1.3 | -0.4 | 0.0 | 0.8 | 1.0 | -0.5 | 0.0 | -0.1 | |
| – | – | – | – | – | – | 0.0 | – | 10 | 12 | |
| – | – | – | – | – | 0.0 | 1.3 | 10 | 2.9 | 4.9 | |
| 7.3 | 13 | 6.0 | 6.3 | 6.0 | 1.1 | 1.3 | 10 | 13 | 17 | |
| -1.2 | 7.1 | -0.7 | -4.4 | -1.8 | -0.4 | 0.2 | 7.1 | -3.9 | -0.6 | |
| -8.5 | -6.3 | -9.9 | -11 | -7.8 | -2.4 | -2.1 | -3.0 | -17 | -18 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.